Sheridan Capital Partners announced on October 7, 2026, the successful closing of two new funds, securing a combined $1.345 billion in institutional capital for investments in the healthcare sector. The private equity firm’s new flagship fund, Sheridan Capital Partners Fund IV, closed at its hard cap of $1.1 billion. In a simultaneous expansion of its strategy, the firm also launched its first dedicated healthcare information technology fund, Healthcare IT Fund I, with $245 million in capital commitments, according to a company press release distributed by Business Wire.

The law firm Kirkland & Ellis advised Sheridan on the closing of both funds. The total capital raised marks a significant expansion of the firm's investment capacity and signals strong investor confidence in its specialized focus on the healthcare industry.

Rapid Fundraising Signals Strong Investor Demand

The fundraising process for the firm's main vehicle, Fund IV, was exceptionally swift, concluding in under 60 days from its launch. According to Sheridan's announcement, the fund was "meaningfully oversubscribed," a term indicating that investor demand for a stake in the fund exceeded the firm's $1.1 billion limit, or hard cap. This high level of interest came from both new and returning institutional investors.

Sheridan Capital Partners attributed the strong reception to its "disciplined and thesis-driven healthcare investment strategy." The rapid and oversubscribed closing in a competitive market underscores the appeal of the firm's established track record and its focus on specific segments within the healthcare industry.

Flagship Fund IV Nearly Doubles Predecessor

The $1.1 billion raised for Fund IV represents a substantial increase in scale for Sheridan's flagship investment vehicle. The amount is nearly double the $575 million the firm raised for its predecessor, Sheridan Capital Partners Fund III, which closed at its hard cap in July 2023. This significant growth in capital allows the firm to pursue a broader range of opportunities and potentially larger deals.

According to information from its legal advisor, Kirkland & Ellis, Fund IV will continue Sheridan's strategy of investing in businesses across the healthcare landscape. Its specific areas of interest include outsourced services, products and manufacturing, and patient services. This broad mandate allows the flagship fund to deploy capital across various sub-sectors of the healthcare economy.

Sheridan Capital Partners Fund Overview

The closing of Fund IV alongside the new Healthcare IT Fund I marks a significant evolution in Sheridan's strategy, combining a scaled-up flagship vehicle with a new, specialized fund. The following table compares the capital and focus of the firm's three most recent funds, illustrating its growth and strategic expansion.

Comparison of Sheridan Capital Partners' Recent Funds
Fund Name Capital Raised Investment Focus
Sheridan Capital Partners Fund IV (2026) $1.1 billion Businesses across the healthcare landscape, including outsourced services, products, manufacturing, and patient services.
Sheridan Healthcare IT Fund I (2026) $245 million Lower middle-market healthcare information technology organizations within North America.
Sheridan Capital Partners Fund III (2023) $575 million Lower middle-market healthcare companies in North America.

New Fund Targets Healthcare Information Technology

The launch of the $245 million Healthcare IT Fund I represents a new and complementary strategy for Sheridan. This is the firm's first fund dedicated exclusively to the healthcare information technology sector. This vehicle is "strategically focused on partnering with lower middle market healthcare information technology organizations within North America," according to a release from Kirkland & Ellis.

By creating a separate fund, Sheridan can deploy a specialized team and a tailored investment approach to a distinct and rapidly growing segment of the healthcare industry. This move allows the firm to capitalize on opportunities in areas like software, data analytics, and other technology-driven solutions that are transforming healthcare delivery and management, while the main fund continues its broader mandate.

Implications for Healthcare Private Equity

The successful and rapid closing of Sheridan Capital Partners' new funds signals continued strong investor confidence in the lower middle-market healthcare and healthcare IT sectors. The ability to raise nearly double the capital of its prior flagship fund, and to do so in less than two months, points to significant market appetite for specialized, healthcare-focused private equity strategies. The next phase will involve deploying this new capital into new investments.

The measurable indicator of the funds' progress will be future announcements of new platform investments by Sheridan Capital Partners using capital from Fund IV and Healthcare IT Fund I.

Sources